Literature DB >> 18159563

Chlamydial bacteriophage: No role in acute coronary events?

David M Patrick1, Karuna Karunakaran, Adrian R Levy, Kenneth Gin, Valencia Remple, Mei Chong, Heather Abbey, Laura Tarry, Caixia Shen, Robert C Brunham.   

Abstract

BACKGROUND: A relationship between Chlamydia pneumoniae infection and acute coronary syndromes has not been consistently found in published studies. It has been hypothesized that a bacteriophage-infected subset of C pneumoniae may be uniquely equipped to promote atherosclerosis and acute coronary syndromes through the expression of phage genes.
METHODS: The authors performed a pilot case-control study of acute coronary events. Case and control subjects were characterized demographically and according to recognized coronary risk factors. These subjects also provided serum for the detection of antibody to the elementary bodies of C pneumoniae and antibody to the Vp1 protein coded by the phage. Bivariate and multivariate comparisons were performed using statistics appropriate for paired analyses.
RESULTS: Antibodies to C pneumoniae, Vp1 protein or both were not associated with acute coronary events by bivariate or multivariate analysis. As expected, case subjects were significantly more likely to have hypertension, hypercholesterolemia or diabetes mellitus.
CONCLUSION: The present study adds to a growing body of literature that does not support the hypothesized relationship between C pneumoniae (or a phage-infected subset of C pneumoniae) and acute coronary syndromes.

Entities:  

Keywords:  Acute coronary syndromes; Bacteriophage; Case-control study; Chlamydia pneumoniae

Year:  2005        PMID: 18159563      PMCID: PMC2095046          DOI: 10.1155/2005/173147

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  12 in total

1.  Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study.

Authors:  J B Muhlestein; J L Anderson; J F Carlquist; K Salunkhe; B D Horne; R R Pearson; T J Bunch; A Allen; S Trehan; C Nielson
Journal:  Circulation       Date:  2000-10-10       Impact factor: 29.690

2.  Molecular detection and seroepidemiology of the Chlamydia pneumoniae bacteriophage (PhiCpn1).

Authors:  Karuna P Karunakaran; James F Blanchard; Ausra Raudonikiene; Caixia Shen; Andrew D Murdin; Robert C Brunham
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

3.  Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39.

Authors:  T D Read; R C Brunham; C Shen; S R Gill; J F Heidelberg; O White; E K Hickey; J Peterson; T Utterback; K Berry; S Bass; K Linher; J Weidman; H Khouri; B Craven; C Bowman; R Dodson; M Gwinn; W Nelson; R DeBoy; J Kolonay; G McClarty; S L Salzberg; J Eisen; C M Fraser
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

4.  Comparison of whole genome sequences of Chlamydia pneumoniae J138 from Japan and CWL029 from USA.

Authors:  M Shirai; H Hirakawa; M Kimoto; M Tabuchi; F Kishi; K Ouchi; T Shiba; K Ishii; M Hattori; S Kuhara; T Nakazawa
Journal:  Nucleic Acids Res       Date:  2000-06-15       Impact factor: 16.971

5.  Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis.

Authors:  J Danesh; P Whincup; M Walker; L Lennon; A Thomson; P Appleby; Y Wong; M Bernardes-Silva; M Ward
Journal:  BMJ       Date:  2000-07-22

Review 6.  Infection and atherosclerosis: emerging mechanistic paradigms.

Authors:  S E Epstein; Y F Zhou; J Zhu
Journal:  Circulation       Date:  1999-07-27       Impact factor: 29.690

7.  Phage infection of the obligate intracellular bacterium, Chlamydia psittaci strain guinea pig inclusion conjunctivitis.

Authors:  R Hsia; H Ohayon; P Gounon; A Dautry-Varsat; P M Bavoil
Journal:  Microbes Infect       Date:  2000-06       Impact factor: 2.700

8.  Comparative genomes of Chlamydia pneumoniae and C. trachomatis.

Authors:  S Kalman; W Mitchell; R Marathe; C Lammel; J Fan; R W Hyman; L Olinger; J Grimwood; R W Davis; R S Stephens
Journal:  Nat Genet       Date:  1999-04       Impact factor: 38.330

9.  Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial.

Authors:  Christopher M O'Connor; Michael W Dunne; Marc A Pfeffer; Joseph B Muhlestein; Louis Yao; Sandeep Gupta; Rebecca J Benner; Marian R Fisher; Thomas D Cook
Journal:  JAMA       Date:  2003-09-17       Impact factor: 56.272

10.  Association of circulating Chlamydia pneumoniae DNA with cardiovascular disease: a systematic review.

Authors:  Marek Smieja; James Mahony; Astrid Petrich; Jens Boman; Max Chernesky
Journal:  BMC Infect Dis       Date:  2002-10-01       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.